SebiaUSA retweeted
🚨 CALLING ALL Pathologists & Laboratories: reduce variability, identify optimal testing, & improve the accurate diagnosis of patients with #monoclonalgammopathies: capatholo.gy/37pyXHz.
SebiaUSA retweeted
EXCITING NEWS! The CAPILLARYS 3 OCTA is now available! Click here to learn more: ow.ly/2sQY50xpA3u
#sebiausa #sebia #C3O
SebiaUSA retweeted
Thanks to our #topfollowers this week! Have a great weekend!
@SpringBankPharm @SebiaUS @DCHIMA4 @sophiamiller345 @GrowthClimbers @AnniMattew @MatrixCare @KGIpres @AmericanElement @biosciencetoday @rabiuli55048773 @dietssharktank
SebiaUSA retweeted
GSK's anti-BCMA drug hits goal in pivotal multiple myeloma test fiercebiotech.com/biotech/gs…
SebiaUSA retweeted
Multiple myeloma is caused by DNA changes in plasma cells. The exact cause of these changes is not yet known, but great progress is being made to find out #FactFriday
SebiaUSA retweeted
The #2019AACC mobile app is now available to download in both the Apple Store and Google Play. The app is a great way to build an itinerary, search for sessions, find exhibitors and more.
2019aacc.org/app
SebiaUSA retweeted
The 71st AACC Annual Scientific Meeting & Clinical Lab Expo showcases cutting edge science and technology shaping the future of laboratory medicine. Join us in Anaheim, California, from August 4-8. 2019aacc.org/ #2019AACC
youtu.be/lOUddK9dsxk
SebiaUSA retweeted
When we improve diagnosis beyond current practice, we decrease both false negative and false positive classifications. Reducing false negatives for dangerous diseases saves lives, while reducing false positives for benign diseases saves money. https://teapawt.net/t.co/Hh7p6N2Znd
SebiaUSA retweeted
The AACR Future of Cancer Research Innovation Summit on Combination Therapies ends today. We thank this amazing team of leaders in immunotherapy, targeted drug therapies, surgical oncology, & radiation therapy for working to improve the development of combination cancer therapies
SebiaUSA retweeted
Evaluation of the Sebia Free Light Chain assay: comparison with the Freelite assay for the clinical management of diagnosis, response and relapse assessment in multiple myeloma clinical-lymphoma-myeloma-le… – at Duluth, GA



















